Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Hamada

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
JTO Clinical and Research Reports|February 24, 2025
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory StudyShuta Ohara, Kenichi Suda, Sumedha Sudhaman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2023
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 InsertionAkira Hamada, Kenichi Suda, Masaya Nishino, et al.
JTCVS Open|July 10, 2023
Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective studyAkira Hamada, Kazuhiro Kitajima, Kenichi Suda, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 21, 2025
Similar Trend in Benefit of Adjuvant Platinum in Lung Cancer Patients Irrespective of Epidermal Growth Factor Receptor Mutation StatusKenichi Suda, Kosuke Fujino, Mao Yoshikawa, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2025
Clinical utility of the 5-point visual Deauville score for preoperative evaluation in stage I non-small cell lung cancer: A multicenter retrospective studyTomoyo Fukami, Akira Hamada, Kenichi Suda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2025
Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)Akira Hamada, Junichi Soh, Akito Hata, et al.
Clinical Lung Cancer|May 26, 2021
Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L)Akira Hamada, Junichi Soh, Akito Hata, et al.
Annals of Surgical Oncology|February 26, 2026
Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective StudyShinya Tane, Megumi Nishikubo, Takehiko Manabe, et al.
British Journal of Cancer|July 16, 2025
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapyShunsuke A Sakai, Hidekazu Oyoshi, Masaki Nakamura, et al.
International Journal of Cancer|November 21, 2024
Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study)Kotaro Nomura, Kazuki Takada, Fumihiko Kinoshita, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
JTO Clinical and Research Reports|February 24, 2025
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory StudyShuta Ohara, Kenichi Suda, Sumedha Sudhaman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2023
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 InsertionAkira Hamada, Kenichi Suda, Masaya Nishino, et al.
JTCVS Open|July 10, 2023
Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective studyAkira Hamada, Kazuhiro Kitajima, Kenichi Suda, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|July 21, 2025
Similar Trend in Benefit of Adjuvant Platinum in Lung Cancer Patients Irrespective of Epidermal Growth Factor Receptor Mutation StatusKenichi Suda, Kosuke Fujino, Mao Yoshikawa, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 18, 2025
Clinical utility of the 5-point visual Deauville score for preoperative evaluation in stage I non-small cell lung cancer: A multicenter retrospective studyTomoyo Fukami, Akira Hamada, Kenichi Suda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2025
Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)Akira Hamada, Junichi Soh, Akito Hata, et al.
Clinical Lung Cancer|May 26, 2021
Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L)Akira Hamada, Junichi Soh, Akito Hata, et al.
Annals of Surgical Oncology|February 26, 2026
Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective StudyShinya Tane, Megumi Nishikubo, Takehiko Manabe, et al.
British Journal of Cancer|July 16, 2025
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapyShunsuke A Sakai, Hidekazu Oyoshi, Masaki Nakamura, et al.
International Journal of Cancer|November 21, 2024
Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study)Kotaro Nomura, Kazuki Takada, Fumihiko Kinoshita, et al.
Pageof 9